- Motley Fool•3 days ago
Short-sellers have pounced on Intercept's stock. But could their pessimism be short-sighted?
- GlobeNewswire•4 days agoIntercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences
NEW YORK, Feb. 17, 2017-- Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, ...
- Investopedia•7 days ago
Intercept stock rose 3.5% after the FDA allowed a redesign of late stage trial for its liver drug.
ICPT : Summary for Intercept Pharmaceuticals, Inc. - Yahoo Finance
Intercept Pharmaceuticals, Inc. (ICPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||125.11 x 200|
|Ask||125.38 x 100|
|Day's Range||124.96 - 128.99|
|52 Week Range||96.63 - 177.93|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.07|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|